Printer friendly formatSome Research on Vaccinations
and ADHD, Autism, Asthma
Home ||| Research Menu Page ||| Last update 12/29/05
Mutter 2005 Mercury and autism: Accelerating Evidence? Mutter 2005 Amalgam risk assessment with coverage of references up to 2005 (Review) Brown 2001 Theoretical estimation of blood mercury levels from Thimerosal injections using a one compartment biokinetic model Megson 2000 Presentation to House Government Reform Committee on Autism and Vaccines Yazbak 2002 Live virus vaccination near a pregnancy: flawed policies, tragic results. Yoneyama 2000 The effect of DPT and BCG vaccinations on atopic disorders
.
- Theoretical estimation of blood mercury levels from Thimerosal injections using a one compartment biokinetic model, Brown, D, IOM Meeting on Thimerosal and Vaccines
" While the estimates of exposure from Thimerosal do not exceed these risk predictions they are in the same range and, with additivity from other sources, may contribute to an elevated mercury approaching these levels. The National Research Council in 2000 expert panel reviewed the available studies of mercury exposure and toxic outcomes and suggested a BMDL of 58 ppb Hg in cord blood ( corresponding to 12 ppm in maternal hair). These levels are also in the same order of magnitude estimated in this probe study. There is a notably relatively low margin of safety for mercury in the current studies and recommendations. 1. Because the estimated levels of mercury in blood and hair after Thimerosal are in the same order of magnitude as those levels which induce toxic actions in humans with accidental exposures, it is important to obtain a more detailed kinetic analysis using more exact transfer factors and a more complete model. 2. Additivity with other mercury exposures such as fish is a serious possibility and requires caution and re-enforcement of state mercury consumption advice to parents of young children. 3. Because the risk to children is believed to be as much as 10 times greater than risk to adults, the fact that estimates are slightly below the toxic levels would not be considered evidence of safety."- Presentation to House Government Reform Committee on Autism and Vaccines, Megson, M, April 6, 2000
" In the vast majority of these cases, one parent reports night blindness . . . caused by a genetic defect in a G protein, . . . Close to the age of "autistic regression," we add pertussis toxin, which completely disrupts G Alpha signals. The opposite G proteins are on without inhibition . . .I think we are staring a disaster in the face that has affected thousands of Americans. . . .
These children are physically ill, immuno-suppressed with a chronic autoimmune disorder affecting multiple organ systems. Funding to look at etiology of autism, to identify children at risk prior to "autistic regression," and to prevent this disorder is imperative. Implementing vaccine policies that are safe for all children should become our first priority. "
- Mercury and autism: Accelerating Evidence?, Mutter J, Naumann J, Schneider R, Walach H, Haley B. Neuro Endocrinol Lett. 2005 Oct;26(5):439-46.
" Institute for Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg, Germany. joachim.mutter@uniklinik-freiburg.de.. . . Recently, it was found that autistic children had a higher mercury exposure during pregnancy due to maternal dental amalgam and thimerosal-containing immunoglobulin shots. It was hypothesized that children with autism have a decreased detoxification capacity due to genetic polymorphism. In vitro, mercury and thimerosal in levels found several days after vaccination inhibit methionine synthetase (MS) by 50%. . . . Repetitive doses of thimerosal leads to neurobehavioral deteriorations in autoimmune susceptible mice, increased oxidative stress and decreased intracellular levels of glutathione in vitro. Subsequently, autistic children have significantly decreased level of reduced glutathione. Promising treatments of autism involve detoxification of mercury, and supplementation of deficient metabolites. "
- Amalgam risk assessment with coverage of references up to 2005 Mutter J, Naumann J, Walach H, Daschner F., Gesundheitswesen. 2005 Mar;67(3):204-16.
" Institut fur Umweltmedizin und Krankenhaushygiene, Universitatsklinik Freiburg. joachim.mutter@uniklinik-freiburg.de. . .Amalgam contributes substantially to human mercury load. Mercury accumulates in some organs, particularly in the brain, where it can bind to protein more tightly than other heavy metals (e. g. lead, cadmium). Therefore, the elimination half time is assumed to be up to 1 - 18 years in the brain and bones. Mercury is assumed to be one of the most toxic non-radioactive elements. . . . Review of recent literature suggests that mercury from dental amalgam may lead to nephrotoxicity, neurobehavioural changes, autoimmunity, oxidative stress, autism, skin and mucosa alterations or non-specific symptoms and complaints. The development of Alzheimer's disease or multiple sclerosis has also been linked to low-dose mercury exposure. There may be individual genetical or acquired susceptibilities for negative effects from dental amalgam. Mercury levels in the blood, urine or other biomarkers do not reflect the mercury load in critical organs. Some studies regarding dental amalgam reveal substantial methodical flaws. Removal of dental amalgam leads to permanent improvement of various chronic complaints in a relevant number of patients in various trials. Summing up, available data suggests that dental amalgam is an unsuitable material for medical, occupational and ecological reasons. "
- Live virus vaccination near a pregnancy: flawed policies, tragic results. Yazbak FE, Yazbak K, Med Hypotheses. 2002 Sep;59(3):283-8.
" Vaccination of women with live virus vaccines around conception has always been contraindicated by the Center for Disease Control and Prevention (CDC) and the vaccine manufacturer because of potential risks to the fetus. Nevertheless this dangerous practice occurs and is associated with maternal health problems and a very high incidence of early-onset autism in the children.Postpartum vaccination with live virus vaccines has been recommended by the CDC, and described as 'convenient' by the vaccine manufacturer. This 'routine practice' . . .is also associated with many health and obstetrical problems in the recipient, and is frequently associated with autism in both current and future children. Re-vaccination often fails to produce immunity, the very reason for which it was recommended. "- The effect of DPT and BCG vaccinations on atopic disorders. Yoneyama H, Suzuki M, Fujii K, Odajima Y, Arerugi 2000 Jul;49(7):585-92
" ...Among the 82 children aged 0-3, out of the 39 who received DPT vaccination, 10 (25.6%) suffered from bronchial asthma and this ratio was significantly higher than among the children who have not received DPT vaccination (1 in 43, 2.3%), ... This was also the case concerning atopic dermatitis (... 18.0% vs ... 2.3%) . ... if ... (bronchial asthma, allergic rhinitis and atopic dermatitis) were combined (... 56.4% vs ... 9.3%) ... From these results, we conclude that DPT vaccination has some effect in the promotion of atopic disorders, ..."